Premium
Mutational Analysis of Nicotinic Acetylcholine Receptor β2 Subunit Gene ( CHRNB2 ) in a Representative Cohort of Italian Probands Affected by Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
Author(s) -
Duga Stefano,
Asselta Rosanna,
Bonati Maria Teresa,
Malcovati Massimo,
Dalprà Leda,
Oldani Alessandro,
Zucconi Marco,
FeriniStrambi Luigi,
Tenchini Maria Luisa
Publication year - 2002
Publication title -
epilepsia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.687
H-Index - 191
eISSN - 1528-1167
pISSN - 0013-9580
DOI - 10.1046/j.1528-1157.2002.39001.x
Subject(s) - proband , nocturnal , acetylcholine receptor , nicotinic acetylcholine receptor , epilepsy , nicotinic agonist , protein subunit , cohort , frontal lobe , endocrinology , genetics , receptor , medicine , biology , neuroscience , psychology , gene , mutation
Summary: Twenty‐four autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) probands were analyzed for the presence of V287L and V287M mutations in the CHRNB2 gene, which have been recently associated with the disease. In all patients, the involvement of the two additional loci reported as being associated with ADNFLE ( CHRNA4 gene and chromosome 15q24 region) had been previously excluded. Mutational screening was performed by sequencing a polymerase chain reaction–amplified CHRNB2 DNA fragment, spanning the whole exon 5, which contains the V287L and V287M mutations and codes for ∼65% of the mature protein. In none of the patients were mutations in the analyzed region of CHRNB2 found. These data, obtained in the largest ADNFLE cohort so far analyzed, demonstrate the rarity of the identified CHRNB2 mutations in ADNFLE patients.